| 000 | 01155 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515182835.0 | ||
| 264 | 0 | _c20091221 | |
| 008 | 200912s 0 0 eng d | ||
| 022 | _a1860-7187 | ||
| 024 | 7 |
_a10.1002/cmdc.200900213 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKeller, Max | |
| 245 | 0 | 0 |
_aBivalent argininamide-type neuropeptide y y(1) antagonists do not support the hypothesis of receptor dimerisation. _h[electronic resource] |
| 260 |
_bChemMedChem _cOct 2009 |
||
| 300 |
_a1733-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aArginine _xanalogs & derivatives |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aNeuropeptide Y _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein Multimerization _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Neuropeptide Y _xantagonists & inhibitors |
| 700 | 1 | _aTeng, Shangjun | |
| 700 | 1 | _aBernhardt, Günther | |
| 700 | 1 | _aBuschauer, Armin | |
| 773 | 0 |
_tChemMedChem _gvol. 4 _gno. 10 _gp. 1733-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cmdc.200900213 _zAvailable from publisher's website |
| 999 |
_c19078879 _d19078879 |
||